Literature DB >> 18342575

Human monocytes represent a competitive source of interferon-alpha in peripheral blood.

Leo Hansmann1, Sabine Groeger, Werner von Wulffen, Gregor Bein, Holger Hackstein.   

Abstract

Interferon-alpha (IFN-alpha) has a critical role in antiviral immunity and plasmacytoid dendritic cells (pDCs) have been demonstrated as the principal IFN-alpha source after Toll-like receptor (TLR) 7 and 9 stimulation. Little is known about the contribution of pDC-independent IFN-alpha sources to total IFN-alpha production capacity of human peripheral blood. Using an array of pathogen associated molecular patterns (PAMPs), Poly(I:C)/Dotap represented the second strongest IFN-alpha stimulus in total PBMC. Poly(I:C)/Dotap induced three times more IFN-alpha, when compared to TLR7-stimulation (R848) and four times less, when compared to TLR9-stimulation. Dotap (mediator of cellular uptake) dramatically increased Poly(I:C)-induced IFN-alpha production. Sorting experiments and ELISpot assays revealed that monocytes and not myeloid DCs are the main IFN-alpha source after Poly(I:C)/Dotap stimulation. ELISpot analyses demonstrated the highest IFN-alpha spot numbers after Poly(I:C)/Dotap stimulation. Although pDCs produced highest IFN-alpha levels per cell, monocytes represent a competing IFN-alpha source in total PBMC due to their high frequency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342575     DOI: 10.1016/j.clim.2008.01.014

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  17 in total

Review 1.  PPARgamma as a potential therapeutic target in pulmonary hypertension.

Authors:  Roy L Sutliff; Bum-Yong Kang; C Michael Hart
Journal:  Ther Adv Respir Dis       Date:  2010-06       Impact factor: 4.031

2.  Genetic vaccines to potentiate the effective CD103+ dendritic cell-mediated cross-priming of antitumor immunity.

Authors:  Yi Zhang; Guo Chen; Zuqiang Liu; Shenghe Tian; Jiying Zhang; Cara D Carey; Kenneth M Murphy; Walter J Storkus; Louis D Falo; Zhaoyang You
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

3.  Buffering capacity and size of siRNA polyplexes influence cytokine levels.

Authors:  Qixin Leng; Szu-Ting Chou; Puthupparampil V Scaria; Martin C Woodle; A James Mixson
Journal:  Mol Ther       Date:  2012-10-02       Impact factor: 11.454

4.  Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma.

Authors:  Yi Lin; Michael P Gustafson; Peggy A Bulur; Dennis A Gastineau; Thomas E Witzig; Allan B Dietz
Journal:  Blood       Date:  2010-11-09       Impact factor: 22.113

5.  C1q-mediated repression of human monocytes is regulated by leukocyte-associated Ig-like receptor 1 (LAIR-1).

Authors:  Myoungsun Son; Betty Diamond
Journal:  Mol Med       Date:  2015-02-05       Impact factor: 6.354

6.  Human Cytomegalovirus Utilizes a Nontraditional Signal Transducer and Activator of Transcription 1 Activation Cascade via Signaling through Epidermal Growth Factor Receptor and Integrins To Efficiently Promote the Motility, Differentiation, and Polarization of Infected Monocytes.

Authors:  Donna Collins-McMillen; Emily V Stevenson; Jung Heon Kim; Byeong-Jae Lee; Stephen J Cieply; Maciej T Nogalski; Gary C Chan; Robert W Frost; Caroline R Spohn; Andrew D Yurochko
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

7.  Co-expression of miRNA targeting the expression of PERK, but not PKR, enhances cellular immunity from an HIV-1 Env DNA vaccine.

Authors:  Adam K Wheatley; Marit Kramski; Marina R Alexander; Jesse G Toe; Rob J Center; Damian F J Purcell
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

8.  Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?

Authors:  David E Green; Roy L Sutliff; C Michael Hart
Journal:  Pulm Circ       Date:  2011-01-01       Impact factor: 3.017

9.  Type I interferon-dependent gene MxA in perinatal HIV-infected patients under antiretroviral therapy as marker for therapy failure and blood plasmacytoid dendritic cells depletion.

Authors:  Raffaele Badolato; Claudia Ghidini; Fabio Facchetti; Federico Serana; Alessandra Sottini; Marco Chiarini; Elena Spinelli; Silvia Lonardi; Alessandro Plebani; Luigi Caimi; Luisa Imberti
Journal:  J Transl Med       Date:  2008-09-09       Impact factor: 5.531

10.  IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity.

Authors:  Lisa F P Ng; Angela Chow; Yong-Jiang Sun; Dyan J C Kwek; Poh-Lian Lim; Frederico Dimatatac; Lee-Ching Ng; Eng-Eong Ooi; Khar-Heng Choo; Zhisheng Her; Philippe Kourilsky; Yee-Sin Leo
Journal:  PLoS One       Date:  2009-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.